Track market-moving stories before they get noisy

BlackRock Canada launched two exchange-traded funds Monday, including a portfolio that combines globally diversified equities with a 3% allocation to Bitcoin.

The two funds, which began trading on the Toronto Stock Exchange, are the iShares Equity + Bitcoin ETF Portfolio (IBQT) and the iShares Core MSCI All-International Equity Index ETF (XINT).

IBQT allocates 97% of its portfolio to Canadian, US, international and emerging-market equities and 3% to Bitcoin (BTC) exposure through BlackRock’s Canadian iShares Bitcoin ETF (IBIT), which trades on Cboe Canada. Rather than investing in individual stocks, IBQT primarily holds other iShares ETFs to provide its equity and Bitcoin exposure.

XINT tracks the MSCI ACWI ex North America IMI Index, providing exposure to more than 5,000 companies across over 40 developed and emerging markets outside Canada and the US.

Both funds are managed by BlackRock Asset Management Canada through the RBC iShares alliance. BlackRock said its iShares business managed approximately $6.2 trillion in assets across more than 1,700 ETFs as of June 30.

The asset management giant’s US-listed iShares Bitcoin Trust (IBIT) is the largest US spot Bitcoin ETF by assets under management, with about $47.9 billion in AUM, according to CoinMarketCap data.

Top five US spot Bitcoin ETFs by AUM. Source: CoinMarketCap

Magazine: BIP-110 ends with a whimper, CLARITY vote punted: Hodler’s Digest, Aug. 9

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently.

Robinhood has expanded its UK investing app into crypto, giving eligible customers access to more than 50 digital assets while adding an AI-powered tool to explain market moves.

UK customers can now buy and sell more than 50 cryptocurrencies, including Bitcoin, Ethereum, XRP and Hyperliquid, through Robinhood’s main app. The service operates through Bitstamp UK, the crypto exchange Robinhood acquired for $200 million last year.

The company said there are no trading, custody or account maintenance fees. Customers will instead pay a 0.1% foreign exchange fee when converting currencies, while some weekend conversions carry a 0.3% fee.

The rollout follows Robinhood’s registration with the Financial Conduct Authority (FCA) on July 31. Bitstamp UK is also FCA-registered. Crypto assets held through the service are not covered by the Financial Services Compensation Scheme or the Financial Ombudsman Service.

Cortex brings AI into crypto tradingAlongside the trading launch, Robinhood is introducing Cortex Digests for Crypto. The generative AI feature reviews breaking news, market data, technical indicators and Robinhood’s own insights to explain what may be driving price movements.

The vision is to give users a simple market summary without making them dig through multiple sources.

Robinhood expands its crypto ecosystemThe company is also pushing its blockchain business through Robinhood Chain, a Layer 2 network built using Arbitrum technology. Robinhood said the network has recorded more than $18 billion in decentralized exchange trading volume and over $840 million in total value locked since its July 1 launch.

Developers, including those in the UK, can build applications on the network.

UK rules will tighten furtherRobinhood’s launch comes before the UK’s new crypto authorization regime. Applications are expected to open in September 2026, with the new framework scheduled to take effect in October 2027. Robinhood’s current FCA registration will not replace the authorization required under that future system.

The UK expansion also comes as Robinhood’s crypto transaction revenue fell 38% year over year to $100 million in Q2 2026. Still, total revenue rose 32% to $1.31 billion, while prediction-market revenue reached $156 million.

Story Ends Here

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

Read the Next News

In brief Bitmine bought 7,391 ETH over the past week, down from 10,399 the week before, taking holdings to 5,805,238 ETH. Total crypto, cash and "moonshot" holdings reached $11.6 billion, up from $11.3 billion. Cash and marketable securities fell to $104 million, from $482 million a month ago. Ethereum treasury company Bitmine Immersion Technologies said Monday it bought 7,391 ETH over the past week, worth about $14 million, taking its holdings to 5,805,238 ETH as of Friday evening. The company bought 10,399 ETH the week before.

Total crypto, cash and what the firm calls "moonshot" investments came to $11.6 billion, up from $11.3 billion. Most of that gain came from price, with ETH up 2.6% over the week to $1,928, adding around $280 million to the value of a stack that grew by $14 million in purchases.

🧵
1/
BitMine provided its latest holdings update for August 10, 2026

$11.6 billion in total crypto + "moonshots":
- 5,805,238 ETH at $1,928 per ETH per ETH (per @coinbase)
- 209 Bitcoin (BTC)
- $180 million stake in Beast Industries @MrBeast
- $69 million stake in Eightco…

— Bitmine (NYSE-BMNR) $ETH (@BitMNR) August 10, 2026

The firm's cash position continues to thin, with cash and marketable securities standing at $104 million, down from the $173 million it reported a week earlier and $482 million the company reported for July 12—a decline of 78% in a month. Alongside the ETH, Bitmine holds 209 Bitcoin, a $180 million stake in Beast Industries and $69 million of Eightco Holdings.

Bitmine repurchased 3 million shares over the week, down from 4.5 million, bringing the total to 19.1 million since July 1 under a $4 billion authorization. Chairman Tom Lee said the company "continues to view Bitmine's common shares as undervalued," and called the program the largest executed by any crypto treasury company.

Staking now covers 5,067,309 ETH, or 87% of holdings, up from 85% a week earlier. Lee put projected annualized staking revenue at $257 million, based on a seven-day yield of 2.63%.

The last 4%Bitmine's stack is 4.8% of Ethereum's 120.7 million supply, and the company again described itself as 96% of the way to its "Alchemy of 5%" target, the same figure it gave a week ago and the fifth straight week at 4.8%. Reaching 5% would take about 229,800 more ETH, or roughly 31 weeks at last week's rate.

The firm has bought ETH every week since starting the strategy on June 30, 2025. It picked up $214 million worth in June during a selloff Lee called "superficial," added $49 million in July on early demand for Robinhood Chain, then eased off later that month before passing 5.79 million ETH.

Lee said he was “disappointed” the Clarity Act would not reach a Senate vote before the August recess, but pointed to softer inflation and jobs data, putting the odds of a September Federal Reserve hike at 40%, down from 75% a fortnight ago. Those odds have since risen to 46%, according to CME FedWatch.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

Cover image via U.Today Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Ethereum co-founder Vitalik Buterin has presented a major update to the network's technological direction, radically changing its development priorities. The "Strawmap" he published eliminates the old six-phase roadmap — including the Merge, the Surge and others — and divides the blockchain's evolution into three architectural layers: consensus (CL), data (DL) and execution (EL).

The main marker of the new strategy is Ethereum's official shift toward protection against future quantum computers, comprehensive user privacy and the integration of AI tools for code verification, while abandoning several older technological ideas.

"Ethereum will be quantum-safe. Ethereum will put users' privacy first. Ethereum will be secure. Ethereum will be censorship-resistant. Ethereum will be highly performant and scalable while satisfying the above. And Ethereum will be Lean." — Vitalik Buterin

HOT Stories

What prompted the overhaul of the old Ethereum roadmapExpectations that powerful quantum computers could emerge soon have forced researchers to rewrite the security roadmap with the introduction of a post-quantum public-key registry and PQ transactions. 

Buterin emphasized that the roadmap now includes "aggressive scaling in the context of post-quantum," involving lightweight LeanSPHINCS signatures and "zkzk" cryptographic frameworks.

To achieve this, developers have made difficult trade-offs: Verkle trees, which had been under development for years, have officially been declared obsolete. According to Buterin, some elements were "replaced with superior constructions." 

Newly updated Ethereum "Strawmap" outlining the network's technical timeline across three layers, Source: Vitalik Buterin via X.comIn this case, Verkle trees gave way to Poseidon binary trees (PBTs), originally designed to work efficiently with the complex mathematics of STARK proofs.

You Might Also Like

Buterin acknowledged that previous roadmaps critically lacked built-in privacy tools and that the network now requires "first-class attention to strong privacy." Keyed nonces, elements of FOCIL, lean privacy pools and a "wormhole" architecture are being integrated into the protocol to make it possible to conduct fully shielded transfers directly at the network's base layer.

Why Ethereum's economics are changing and what exactly AI will controlInstead of attempting to "maximally scale ALL Ethereum activity," developers are creating specialized mechanisms that have more restrictive properties. They are intended to support "the heaviest loads incurred by users and applications today and tomorrow," including token transfers, fast swaps and privacy protocols. 

The technical foundation of this approach will consist of recursive STARK proofs and native rollups, which could not even have been considered in 2023 because "SNARKs were nowhere near mature enough."

You Might Also Like

At the same time, Ethereum's economics are being reformed. Short- and long-term futures for gas and blobs have been added to the roadmap, with Buterin separately noting that this idea simply did not exist back in 2023. 

This will allow major applications to purchase network capacity in advance at a fixed price, protecting users from sudden fee spikes.

The security of such a densely integrated architecture will be possible only through end-to-end formal verification (FV) of protocol specifications. Buterin plans to entrust this task entirely to modern AI tools, as the volume of code has already become too large for humans to verify on their own.

BLOG August 10, 2026

This patch release introduces several improvements to v0.6.1 and adds the new GovPaymaster system contract to improve the ERC-4337 user experience. Upgrading from v0.6.1 is highly recommended, especially for MainNet nodes.

Upgrade Instructions Follow the steps below to upgrade your node from v0.6.1 to v0.6.2:

Download the new binary from the release page.

Gracefully stop your node.

Replace the old binary with the new one.

Restart your node.

New Feature Add the GovPaymaster system contract and related network policy.

Behavior Changes Prevent rewards from being sent to validators using EIP-7702 delegation.

Extend the Blacklist Policy to EVM execution.

Improvements Improve hardfork listings in the node log.

Detach the extensible payload verifier from the dBFT engine.

Support optional rewind during genesis initialization.

If you have any questions regarding this upgrade, please reach out in our Discord community.

Please beware of scammers impersonating Neo via direct messages. Follow Neo for future updates.

Cover image via depositphotos.com Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

At the start of the new week, two major treasury transactions were recorded in the stablecoin market, clearly illustrating the division of digital capital into two parallel and non-overlapping directions.

According to on-chain tracker, Ripple carried out a scheduled issuance of $10 million in RLUSD stablecoins on the XRP Ledger. Almost simultaneously, Tether conducted a routine issuance of $1 billion in USDT on the Tron blockchain, increasing its treasury inventory on the network to $91 billion.

The difference in volume is explained by the fundamentally different business models of the two issuers. 

HOT Stories

You Might Also Like

With its enormous turnover, Tether serves the needs of the mass retail market and crypto trading, where immediate access to deep liquidity is critical.

Fresh $10 million RLUSD mint on XRP Ledger (XRPL) by Ripple, Source: XRP ScanRipple, in turn, is not attempting to compete in the mass-market segment. RLUSD currently has a market capitalization of $1.52 billion, approximately 20% below its May peaks, while the token is issued selectively to meet specific B2B requests from commercial companies through the Ripple Mint platform.

Whales defend $1 XRP floor as Ripple injects fresh capitalThe latest $10 million mint coincided with a major increase in large-investor activity on the spot market. While Ripple's treasury regulates the stablecoin's supply under NYDFS supervision, large holders, or whales, began aggressively moving funds and accumulated more than 380 million XRP over the past week.

These maneuvers unfolded around the psychologically important $1 level for XRP, which major players are defending as a key support level.

You Might Also Like

Ultimately, these developments reflect the current status quo. While Tether retains its position as the main settlement instrument in retail crypto transactions, Ripple is testing its B2B product within the narrow corporate payments niche and undergoing technical adaptation as large investors build positions ahead of a potential breakout from the market's prolonged summer consolidation.

On paper, NuScale Power (SMR -4.48%) failed to meet expectations when it reported quarterly earnings on Aug. 5. The nuclear power stock reported a quarterly loss of $0.13 per share, in line with expectations. Revenue, however, came in at just $80,000 for the quarter, missing estimates by 93%. Sales were down 99% versus the quarter prior.

These are poor figures for a company that supposedly has massive long-term growth potential. Yet shares traded mostly flat following earnings, with the stock price roughly where it was before the earnings announcement.

The reality is that very little was expected of the company this quarter anyway. No major catalysts were expected to be revealed, and the company has no commercial projects underway, despite an impressive pipeline of interested customers. Revenue and profits, therefore, were always expected to be minimal and, in some ways, irrelevant to the company's long-term future.

When might a meaningful growth catalyst arrive? Good news could be on the way later this year regarding NuScale's biggest project.

Today's Change

(

-4.48

%) $

-0.44

Current Price

$

9.38

NuScale Power stock could receive a massive boost later this year Nuclear energy is experiencing a renaissance. Some of that is due to climate concerns and a rising global need for low-carbon energy sources. Most of it, however, is due to rising energy demand across the board, driven by the rapid adoption of energy-intensive AI technologies. The Energy Information Administration observes:

[W]e forecast U.S. annual electricity consumption will increase in 2025 and 2026, surpassing the all-time high reached in 2024. This growth contrasts with the trend of relatively flat electricity demand between the mid-2000s and early 2020s. Much of the recent and forecasted growth in electricity consumption is coming from the commercial sector, which includes data centers.

Still, a resurgence in electricity demand translates to just a few percentage points of annual growth, and getting new energy sources online can often take years. In short, this is a massive opportunity, but it will take decades to fully play out.

Image source: Getty Images.

Investors, therefore, shouldn't expect major revelations during every NuScale earnings release. That's especially true since the company has yet to break ground on any of its SMR deals.

Why hasn't NuScale begun construction? None of its customers have committed to payments. NuScale will only start construction once funds are legally obligated to pay for the construction. NuScale's inability to reach this milestone is a big reason why its valuation remains under $4 billion despite operating in a long-term growth market.

However, NuScale's CFO believes that a power purchase agreement could be signed by its utility customer in the U.S. by the end of 2026, committing it to buying power from the future facility, perhaps for decades to come. If a PPA is secured, construction can finally begin.

A signed PPA would likely be a huge boost to NuScale's stock price. It would provide serious social validation of the company's technology and adoption potential. It would also clear up some of NuScale's financing concerns.

To be sure, NuScale's management team has missed self-imposed deadlines before. But if you're looking for high-upside-potential stocks and are willing to take on extra risk, NuScale could be positioned for a stellar second half of 2026.

Key Takeaways Revenues reached $1.2 million, primarily from Oklo's 2026 acquisitions and their service businesses.R&D expenses surged 244.2% as greater engineering activity and employee headcount drove spending higher.Groves achieved first criticality Aug. 5, with initial isotope revenues expected from Idaho in early 2027. Oklo Inc. (OKLO - Free Report) reported a second-quarter 2026 loss of 28 cents per share, wider than the year-ago loss of 18 cents and the Zacks Consensus Estimate of a loss of 17 cents. The bottom line represented a negative earnings surprise of 64.7%. Revenues came in at $1.2 million.

Higher research and development and administrative spending weighed on earnings as OKLO accelerated project execution. Operationally, the company reached first criticality at its Groves isotope facility shortly after quarter-end.

OKLO Revenues Emerge From AcquisitionsSecond-quarter revenues included $800,000 from engineering and consulting services, $168,000 from manufacturing and fabrication services and $242,000 from other activities. OKLO generated no revenues in the year-ago quarter.

The company said revenues primarily resulted from its 2026 acquisitions. In June, it acquired ARMEC and Creative Engineers, adding precision manufacturing, mechanical engineering and chemical process engineering capabilities. The acquired businesses continue serving established third-party customers.

OKLO Costs Climb on Project ExecutionResearch and development expenses jumped 244.2% year over year to $39.5 million. The increase included $14.7 million of higher professional-services costs and $7.1 million of increased employee compensation, reflecting greater engineering activity and an average headcount increase of roughly 109 employees.

General and administrative expenses rose 106.7% to $34.2 million. Higher employee compensation contributed $6.6 million, while professional services added $6.2 million. Interest and dividend income increased 517.1% to $23.21 million, supported by larger cash and marketable-security balances following equity issuances.

The spending increase also comes as competition across advanced nuclear intensifies. NuScale Power (SMR - Free Report) emphasized in its latest quarter that it has spent years building commercial readiness through NRC approvals, conventional low-enriched uranium and a network of more than 60 specialized suppliers. NANO Nuclear Energy (NNE - Free Report) , meanwhile, is investing in the development and licensing of its KRONOS MMR while pursuing vertical integration across the nuclear fuel cycle.

OKLO Advances Aurora DeploymentAt Aurora-INL, the Department of Energy approved the Preliminary Documented Safety Analysis, establishing the preliminary safety basis needed to advance final design and construction. Site mobilization is underway, while excavation for the reactor area was nearing completion at the time of the earnings call.

OKLO is also advancing its planned 1.2-gigawatt Ohio power campus. An MOU with Kiewit covers engineering, procurement, construction and execution planning for the initial phase. The Zacks Rank #4 (Sell) company is progressing PJM interconnection applications, transmission planning and related technical studies for the site.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The push toward larger power opportunities reflects a broader industry focus on serving data centers and other energy-intensive customers. NuScale Power said it remains in discussions with hyperscalers and is supporting potential large-scale deployments through its commercial partner ENTRA1 Energy. NANO Nuclear has similarly highlighted data-center demand, completing a feasibility study for its KRONOS MMR to provide up to 1 gigawatt of power for BaRupOn's planned AI data-center and manufacturing campus in Texas.

OKLO Expands Its Fuel Supply StrategyOKLO is taking several steps to secure the fuel needed for its future reactors. The company signed a letter of intent with Centrus for enough high-assay low-enriched uranium (HALEU) to support the initial reactor cores and reloads for up to five Aurora powerhouses over several years. Deliveries are expected to begin in 2029. OKLO is also exploring government-supplied materials and fuel recycling to diversify its fuel sources.

Equipment for the Aurora Fuel Fabrication Facility is now being produced, with installation and start-up activities planned for 2027. OKLO is also advancing engineering and preparations for a license application for its Advanced Fuel Center in Tennessee. In addition, the company is in advanced discussions with the Department of Energy about potentially using surplus plutonium as reactor fuel.

OKLO’s Groves Facility Reaches CriticalityOKLO reached another important milestone when its Groves isotope facility achieved first criticality on Aug. 5, less than a year after construction began. The company said major construction work was completed in just 229 days. The project was built on private land using private funding and commercial suppliers, with safety oversight from the Department of Energy.

OKLO sees Groves as an example of how it could develop future nuclear projects more quickly. The project gave the company experience in areas ranging from purchasing and construction to regulatory approval, testing and operations. OKLO expects Groves to begin producing research and development quantities of isotopes in about 12 months, while its Idaho laboratory is expected to generate initial isotope revenues in early 2027.

OKLO Raises 2026 Cash-Use OutlookOklo ended June with $3 billion in cash, cash equivalents and marketable debt securities. Cash used in operating activities totaled $65.5 million during the first six months, while purchases of property, plant and equipment reached $126.9 million.

Management raised its 2026 operating cash-use forecast to $120-$150 million from $80-$100 million. The company also lifted its expected property, plant and equipment spending to $400-$500 million from $350-$450 million, reflecting accelerated Aurora-INL procurement and construction activity and an opportunistic fuel purchase for future isotope projects.

Peer liquidity is also sizable: NuScale Power ended the second quarter with approximately $1.9 billion in cash, cash equivalents and investments, while NANO Nuclear reported approximately $569 million in cash, cash equivalents and short-term investments. Against that backdrop, OKLO's $3 billion liquidity position provides substantial capacity to support its accelerated deployment and fuel strategy.

USD/CAD trades on the back foot on Monday even as the US Dollar (USD) regains some ground after weakening last week following softer-than-expected US Nonfarm Payrolls (NFP) data. Attention now turns to Wednesday’s US Consumer Price Index (CPI) report. At the time of writing, the pair trades around 1.3932, near its lowest level in two months.

The Canadian Dollar (CAD) draws support from stronger-than-expected domestic labour data and rising Oil prices. West Texas Intermediate (WTI) trades around $80.37 per barrel, up 5.20% on the day.

USD/CAD dip below 1.40 puts focus on US CPI and Fed pricingAccording to TD Securities, the latest payrolls data “broke USD/CAD below 1.40,” as the sharp reaction to the contrasting US and Canadian labour market outcomes underscored that “the market remains focused on both central-bank divergence and Canada's domestic outlook.” On the Canadian side, the bank notes that “recent developments in the Canadian economy have evolved broadly in line with our forecasts,” and that while the data surprise is “briefly pushing USD/CAD below the 1.40 support level,” they “think the bearish USD momentum may not sustain unless US CPI also surprises lower to allow market to price out near-term Fed rate hiking odds.”

From a technical perspective, USD/CAD has formed a series of lower highs and lower lows since briefly rising above 1.4200 in late June. The pair holds below the 1.4000 psychological mark and the 50-day Simple Moving Average (SMA) at 1.4075, keeping the near-term bias tilted to the downside.

Momentum indicators also favour sellers. The Relative Strength Index (RSI) sits near 33, approaching oversold territory, while the Moving Average Convergence Divergence (MACD) indicator stays in negative territory.

On the downside, the 100-day SMA near 1.3916 offers initial support, followed by the 200-day SMA around 1.3853. A decisive break below the latter could open the door to a deeper decline.

On the topside, the 1.4000 psychological mark acts as immediate resistance, followed by the 50-day SMA at 1.4075. A recovery above this moving average would ease the bearish pressure.

(The technical analysis of this story was written with the help of an AI tool. Know more.)

Canadian Dollar Price Today The table below shows the percentage change of Canadian Dollar (CAD) against listed major currencies today. Canadian Dollar was the strongest against the Japanese Yen.

USDEURGBPJPYCADAUDNZDCHFUSD0.10%-0.24%0.72%-0.06%0.05%0.10%0.20%EUR-0.10%-0.33%0.61%-0.17%-0.04%-0.00%0.10%GBP0.24%0.33%0.97%0.17%0.31%0.33%0.44%JPY-0.72%-0.61%-0.97%-0.80%-0.69%-0.68%-0.52%CAD0.06%0.17%-0.17%0.80%0.06%0.18%0.25%AUD-0.05%0.04%-0.31%0.69%-0.06%0.02%0.15%NZD-0.10%0.00%-0.33%0.68%-0.18%-0.02%0.11%CHF-0.20%-0.10%-0.44%0.52%-0.25%-0.15%-0.11% The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the Canadian Dollar from the left column and move along the horizontal line to the US Dollar, the percentage change displayed in the box will represent CAD (base)/USD (quote).

Key Takeaways SIMO's Q2 revenue jumped 127% year over year to $451 million, topping prior guidance.SIMO expects Q3 revenue of $519-$541 million, implying 15-20% sequential and 114-124% annual growth.MonTitan, Gen 5 SSD controllers and embedded storage are expanding SIMO's reach into enterprise and AI. Silicon Motion Technology Corporation (SIMO - Free Report) is benefiting from strong momentum across its storage-controller portfolio, driven by market-share gains, new product ramps and growing exposure to enterprise and artificial intelligence (AI)-related storage applications.

The company’s rapidly expanding embedded storage business, strength in SSD controllers and increasing contribution from enterprise and automotive storage solutions are driving robust top-line growth. These factors position Silicon Motion well to sustain its growth trajectory through the remainder of 2026.

Robust Revenue Growth Bodes Well for SIMOSilicon Motion delivered an impressive second quarter, with revenues surging 127% year over year and 32% sequentially to $451 million. The performance also exceeded the company’s earlier guidance of $393-$411 million, highlighting stronger-than-anticipated demand across its portfolio.

The momentum was broad-based. SSD controller sales increased 50-55% year over year and 5-10% sequentially. eMMC+UFS controller sales jumped 95-100% from the year-ago quarter and 15-20% sequentially. Sales from Ferri and Boot Drive solutions soared 1,690-1,695% year over year and 110-115% sequentially.

The strong performance follows an equally encouraging first quarter, when revenues surged 105% year over year and 23% sequentially to $342.1 million. The sustained acceleration underscores Silicon Motion’s success in expanding its addressable market beyond its traditional consumer NAND flash controller business.

Image Source: Zacks Investment Research

SIMO's Growth Momentum Set to ContinueManagement expects the strong top-line trajectory to continue in the third quarter of 2026. Silicon Motion projects revenues between $519 million and $541 million, indicating sequential growth of 15-20% and year-over-year growth of 114-124%.

At the midpoint of $530 million, the guidance represents another significant step up from second-quarter revenues of $451 million and first-quarter revenues of $342.1 million. The trend suggests that Silicon Motion is not merely benefiting from a favorable comparison with the prior year but is generating substantial sequential expansion as new products and customer programs ramp.

Growth is being supported by several catalysts. The company is expanding its presence in embedded eMMC and UFS controllers, while its 6nm PCIe Gen 5 SSD controller portfolio strengthens its position in higher-performance storage applications. Silicon Motion is also targeting enterprise and AI infrastructure opportunities through its MonTitan enterprise SSD controllers and Enterprise Boot Drive solutions.

The MonTitan platform, in particular, expands Silicon Motion’s addressable market beyond its historically consumer-focused business. Earlier this year, management observed that two customers were already in production and five additional major cloud-service-provider customers were expected to ramp in the latter half.

Price PerformanceSilicon Motion has gained a stellar 241.3% over the past year compared with the industry’s growth of 190.5%. It has also outperformed peers like Advanced Micro Devices, Inc. (AMD - Free Report) and International Business Machines Corporation (IBM - Free Report) . Advanced Micro has gained 180.6% and IBM is up 0.4% over this period. 

One-Year SIMO Stock Price Performance

Image Source: Zacks Investment Research

Estimate Revision TrendEarnings estimates for Silicon Motion for 2026 have moved up 134.9% to $11.16 over the past year, while the same for 2027 has increased 187.2% to $16.34. The positive estimate revision depicts optimism about the stock’s growth potential.

Image Source: Zacks Investment Research

End NoteWith solid fundamentals and healthy revenue-generating potential, driven by robust demand trends, Silicon Motion appears to be a solid investment proposition. Further, a strong emphasis on quality, diligent execution of operational plans and continuous portfolio enhancements are driving more value for customers. An asset-light fabless semiconductor model, solid growth exposure to AI, cloud and automotive markets, with increasing market share in SSD and mobile controllers and continuous innovation in storage technologies are key growth drivers for the company.

The stock has a long-term earnings growth expectation of 53.6% and delivered a trailing four-quarter average earnings surprise of 14%. Silicon Motion sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Riding on a robust earnings surprise history and favorable Zacks Rank, Silicon Motion appears primed for further stock price appreciation. Consequently, investors are likely to profit if they bet on this high-flying stock now.

Silence Therapeutics plc (NASDAQ:SLN) stock is trading higher on Monday after the company reported positive topline outcomes from its Phase 2 SANRECO study assessing divesiran for polycythemia vera. It is a rare, slow-growing blood cancer where the bone marrow makes too many red blood cells.

The extra production thickens the blood, slows down blood flow, and raises the risk of dangerous blood clots, heart attacks, and strokes.

The mid-stage trial successfully met both its primary and key secondary metrics, demonstrating strong efficacy alongside a favorable safety profile in phlebotomy-dependent trial participants.

Read Next

“The SANRECO Phase 2 trial delivered our best-case outcome, confirming the impressive results observed in Phase 1 with dosing every six weeks and demonstrating equally robust and durable effects with quarterly dosing,” said Curtis Rambaran, Chief Medical Officer at Silence.

SANRECO Study Meets Primary Efficacy EndpointsThe 36-week trial evaluated divesiran, a first-in-class short interfering RNA therapy, across 48 patients receiving a 6 mg/kg subcutaneous dose every six or twelve weeks.

Overall, 88% of divesiran-treated patients achieved the primary endpoint—defined as the absence of phlebotomies while maintaining hematocrit levels below 45% between weeks 18 and 36—compared to just 19% of placebo recipients.

Dosing schedules administered every six weeks and every twelve weeks demonstrated response rates of 93.8% and 81.3%, respectively, yielding a placebo-adjusted response rate of 69%.

Secondary Outcomes And Tolerability ProfileThe clinical trial also achieved key secondary endpoints during the 36-week timeframe.

Divesiran significantly decreased phlebotomy (vein puncturing) requirements, with treated subjects averaging 0.2 phlebotomies compared to 2.1 procedures in the placebo arm.

Participants receiving divesiran also showed enhancements in hematocrit management, iron ferritin markers, and symptom reductions recorded through the MPN-SAF Total Symptom Score.

Divesiran was well tolerated throughout the study, showing safety results consistent with earlier clinical evaluations.

No new safety concerns emerged, and reported injection site reactions were infrequent and self-limiting.

Two investigator-reported grade 1 anemia adverse events occurred. Based on these results, a Phase 3 trial comparing twelve-week divesiran administration to placebo is expected to launch in the first half of 2027.

The company reported a cash balance of $72.1 million as of June 30, 2026.

SLN Price Action: Silence Therapeutics shares were up 36.82% at $16.35 at the time of publication on Monday. The stock is trading at a new 52-week high, according to Benzinga Pro data.

Read Next

Image via Shutterstock/ Yomal2233

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Key Takeaways SpaceX shares jumped 26% last week despite heavy AI spending concerns. Retail investors remain bullish on SpaceX's long-term AI growth prospects. ETFs offer diversified exposure to SpaceX while reducing company-specific risks. SpaceX (SPCX - Free Report) closed a key week in the green, with shares climbing about 26%, after the company reported its first earnings as a public company and completed the largest share unlock in its brief trading history (read: SpaceX Stock Loved by Retail Investors: ETFs in Focus).

The two events created back-to-back tests for the stock, either of which could have triggered a sharp selloff. While the stock fell after reporting earnings, the insider share-lockup expiration has boosted the stock. SpaceX stock surged 15.8% on Friday, marking its strongest daily gain, and finished at its highest level since July 15, as quoted on Yahoo Finance.

Earnings Beat Fails To Impress InitiallySpaceX's eventful week began with its second-quarter results on Tuesday. Revenue and adjusted EBITDA exceeded expectations, but the strong results initially failed to reassure investors concerned about soaring AI spending.

The company’s AI capital expenditures jumped to $15.8 billion in the quarter from $7.7 billion in the first quarter. SpaceX shares subsequently plunged 13.6% on Wednesday, marking a new all-time closing low (read: SpaceX Beats Q2 Estimates, Shares Fall: ETFs in Focus).

Biggest Share Unlock Tests Investor ConfidenceThe next major test came Thursday, when 911.5 million shares became eligible for trading for the first time. That represented about 43% more shares than the 638.9 million shares offered in the company's June IPO.

The unlock more than doubled SpaceX’s public float, increasing the freely tradable portion of shares outstanding to 11.8% from 4.9%. With the stock already trading below its IPO price, investors had expected the additional supply to create further selling pressure.

But SpaceX shares rose 6.1% on Thursday, defying expectations that the influx of new shares would weigh on the stock.

Staggered Unlock Structure Limits Immediate PressureSpaceX's share-unlock structure is unusual because the company is not releasing all locked shares at once. Instead, the expiration is staggered across nine tranches over several months. Thursday's tranche was the first and largest.

Morningstar analyst Nicolas Owens said much of the selling pressure may have already been reflected in the stock price, as investors had anticipated the unlock, as quoted on the same Yahoo Finance source.

Retail Enthusiasm Cools But Holds FirmSpaceX surged from its $135 IPO price to an intraday peak of $225.64 on June 16. Since then, the stock has fallen significantly. The stock closed last week at $133.11.

Retail demand has also moderated since the IPO, but investors have remained net buyers. Retail investors purchased about $405 million worth of SpaceX shares during the first five trading sessions, compared with $103 million over the five sessions leading up to the company's earnings report.

AI Story Drives Long-Term OptimismVanda Research believes retail investors are looking beyond SpaceX's near-term financial results and focusing instead on its long-term AI ambitions, as mentioned on Yahoo Finance.

SpaceX is prioritizing long-term growth over near-term cash flow. Despite several risks, CEO Elon Musk projects that SpaceX could generate $1 trillion in annual revenue by 2030, a year earlier than its pre-IPO forecast.

Although the enormous investment raised concerns about the cost of SpaceX's expansion, retail investors appeared to view the spending as an investment in future growth. Notably, SpaceX's AI business posted an operating loss of $1.26 billion in Q2, narrower than analysts' estimate of $2.39 billion.

Revenues from the AI segment came in at $2.56 billion, better than the $2.18 billion expected, according to StreetAccount, as quoted on CNBC.

Upbeat Estimate RevisionsThe Zacks Consensus Estimate calls for a loss of 23 cents per share in 2026 (which was revised up from a loss of 53 cents a week ago), followed by EPS of $1.45 in 2027 (which was raised from 65 cents over the past week).

Three of nine analysts have raised the company's earnings estimate for the ongoing quarter over the past week. Six analysts have raised the earnings estimate for the full fiscal year 2026, and five analysts have raised their estimates for the next fiscal year.

Meanwhile, the Zacks Consensus Estimate for revenues calls for $42.96 billion in 2026 (up 130% year over year), followed by $98.63 billion in 2027 (up 129.6%).

Any Wall of Worry?Despite the strong weekly performance, SpaceX still faces eight additional share-unlock tranches over the coming months. The first and largest hurdle has now passed, but the stock's ability to sustain its recovery will depend on whether the company can continue delivering strong financial results while absorbing the additional share supply.

ETFs in FocusInvestors who have faith in SpaceX’s fundamentals but are in two minds due to the upcoming share-unlock events may tap SpaceX stock through a basket of exchange-traded funds (ETFs). The ETF approach minimizes company-specific concentration risks.

Baron First Principles ETF (RONB - Free Report) , Roundhill Space & Technology ETF (MARS - Free Report) , VanEck Space ETF (WARP - Free Report) , VanEck Space ETF (ORBX - Free Report) , VegaShares SpaceX & Beyond Earth ETF (XSPC - Free Report) and WisdomTree Space Economy Fund (WSPC - Free Report) are ETFs that invest in SpaceX to a significant extent.

Investors should note that heavy AI spending is common among major AI companies, as seen in Big Tech’s massive investments. Hence, concerns over SPCX’s high AI spending are unlikely to weigh on the stock for long.

Key Takeaways In Q2, Serve cut 2026 revenue guidance to $9M-$10M from $26M after removing an expected Uber volume ramp.DoorDash partnership revenues grew nearly 50% sequentially, while recurring revenues topped 50% of total.Serve is building direct merchant access with Beacon and plans another product this fall to broaden demand. Serve Robotics Inc. (SERV - Free Report) used its second-quarter 2026 earnings call to explain a sharp reset in its Uber relationship and 2026 revenue outlook after delivery volume declined for the first time in 17 quarters.

CEO Ali Kashani and CFO Brian Read framed the shift as reallocating fleet capacity and capital toward stronger utilization, recurring revenue and operating alignment.

SERV Recasts the Uber RelationshipCo-Founder and CEO Ali Kashani said lower-than-expected robot utilization through Uber reflected differences over fleet coordination, merchant integration and the operating model, rather than weaker customer or merchant demand.

Kashani said Serve does not currently expect to renew the Uber agreement when it expires in early 2027 unless the operating model improves meaningfully. Discussions with Uber are continuing.

Prior guidance assumed a substantial second-half Uber volume ramp, which Serve removed from the 2026 outlook.

Serve Resets 2026 Outlook and SpendingSERV’s second-quarter revenues were $3.24 million, up 404% year over year and 9% sequentially, but missed the $3.54 million Zacks Consensus Estimate. Non-GAAP net loss was $47.1 million, or 59 cents per share. The reported loss of 80 cents per share was wider than the 69-cent Zacks Consensus Estimate.

Serve cut full-year 2026 revenue guidance to $9 million-$10 million from $26 million.

The company’s 2026 non-GAAP operating expense guidance fell to $140 million-$150 million from $160 million-$170 million. Planned capital expenditures were reduced to about $15 million-$17 million from roughly $25 million.

SERV Leans on Diversified Revenue ChannelsCo-Founder and CEO Ali Kashani highlighted DoorDash as a counterpoint to Uber, saying partnership revenues grew nearly 50% sequentially in the second quarter. He also said another major delivery marketplace partnership was set to be announced.

Kashani said advertising represented nearly half of robotic food-delivery revenues. CFO Brian Read added that campaigns span local and national customers, with robot wraps still the primary format.

The CFO said recurring revenues exceeded 50% of total revenues, supported by hospital robotics. Serve signed seven multiyear hospital contract extensions and added two new hospitals in the first half of 2026.

Serve Builds More Direct Merchant AccessAli Kashani said Serve is developing direct distribution to reduce dependence on any single delivery platform. Beacon, a cellular countertop device, is designed to connect restaurants directly with Serve.

The CEO said almost two-thirds of delivery orders in Serve's operating areas cannot use robotic last-mile delivery because of back-of-house integration barriers. Beacon is intended to work without restaurant internet or point-of-sale integration.

Kashani also said Serve plans another product later this fall aimed at generating direct customer demand and broadening the goods its network can move beyond food.

SERV Q&A Presses Utilization and AutonomyA Northland Capital Markets analyst pressed management on the second-quarter utilization decline. Co-Founder and CEO Ali Kashani said Serve and Uber were not fully aligned on order allocation, fleet organization and operating responsibility.

An Oppenheimer analyst asked how investors should track autonomy efficiency. Kashani said key measures are whether robots become faster, safer and more reliable while supporting revenue growth and margin improvement.

A Ladenburg Thalmann analyst asked about advertising. Both the CEO and CFO said Serve is seeing local and national campaigns plus growing experiential use, but management did not provide separate advertising guidance.

Serve Narrows Priorities After the ResetCFO Brian Read said spending will increasingly focus on autonomy performance, utilization, recurring revenues and gross-margin improvement. He also said Serve is reviewing overlapping G&A and shared services while integrating Diligent Robotics.

Read emphasized that core autonomy and software remain investment areas.

The CFO framed the updated plan around tighter prioritization, with capital focused on robot productivity and operating leverage.

SERV’s Zacks Rank & Style Scores Stay CautiousSERV currently carries a Zacks Rank #3 (Hold). Its Value Score is F, Growth Score is F, Momentum Score is C and VGM Score is F, leaving it without the A or B Style Scores that provide stronger complementary signals to top Zacks Ranks.

The rank does not carry the same positive signal as Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks, while the Style Score hierarchy places C above F but below A and B. The Zacks Rank can change as estimates are revised after the just-reported results.

You can see the complete list of today’s Zacks #1 Rank stocks here.

ToplineGeico, Berkshire Hathaway's largest insurance business, saw earnings decline nearly 45% last quarter as American drivers filed more auto claims and injury costs sharply spiked, delivering a hit to the conglomerate’s most profitable sector.

A Geico insurance office on July 20, 2026 in Washington, DC.

Getty Images

Key FactsGeico's pre-tax underwriting earnings fell to $994 million in the second quarter of 2026, down from $1.82 billion a year earlier—for a decline of nearly 45%, according to Berkshire's quarterly Securities and Exchange Commission filing.

Geico's loss ratio—the share of premiums paid out in claims—rose to 76.6% in the second quarter and 75.3% for the first half of 2026, up nearly five percentage points from the same periods a year earlier.

The filing says the number of bodily injury claims rose 5% in the first half of 2026 and injury claim costs on average jumped 10%, both measures worsening when compared to 2025.

Berkshire's filing reflects a broader trend in the insurance industry where bodily injury claims have surpassed auto physical damage payouts for the first time in history.

WHY HAVE BODILY INJURY CLAIMS INCREASED? CCC Intelligent Solutions, an auto insurance software company, reports bodily insurance claim frequency is up 11% over the past two years and the cost of those claims has jumped 10.3% over the last year and 32% over the last four years. CCC says the increase is not because car crashes are becoming more frequent or more severe, instead pointing to changes in the social environment surrounding injury claims. General affordability, higher medical costs and more aggressive legal strategies have all made alleging injuries and filing lawsuits more attractive, according to industry analyst Erik Bahnsen. In other words, people are more likely to win lawsuits and, in doing so, can avoid shouldering the burden of medical costs on their own. For insurance companies, those bodily injury claims are becoming more expensive due to higher rates of attorney involvement, longer negotiations, higher legal fees and rising health care expenses.

SURPRISING FACTWhile the number of bad car accidents hasn’t substantially changed, the number of minor ones has. What are known as Advanced Driver Assistance Systems, like automatic emergency braking, have successfully cut down on the number of minor, low-speed fender benders. And because there are fewer of those lower-severity collisions, the remaining claims pool is disproportionately weighted toward more intense crashes that may result in physical injuries.

Key backgroundGeico was one of Berkshire Hathaway’s strongest performers heading into 2026, recovering from a period of underwriting losses that prompted significant cost cuts and premium increases in previous years. That turnaround made this year’s second-quarter reversal even more striking when underwriting expenses at Geico surged about 28% in the first half of 2026 versus a year earlier. The filing discloses no significant catastrophe losses in the first half of 2026, meaning the Geico deterioration is purely operational rather than weather-driven. Berkshire’s broader operations held $359.2 billion in cash and Treasury bills as of June 30 and generated about $177.5 billion in insurance float—a financial cushion that masks how sharply Geico's underwriting performance has deteriorated.

FORBES VALUATIONWarren Buffett, the investor known as the "Oracle of Omaha," is worth an estimated $151.4 billion as of Monday, making him the 10th-richest person in the world. Buffett took control of Berkshire Hathaway in 1965 and turned the struggling textile company into a giant holding company, of which he was CEO until stepping down in December at age 95. He remains chairman of the board.

further readingForbesBerkshire Hathaway Earnings Beat As Abel Deploys Buffett’s Cash HoardBy Bill StoneForbesBerkshire Hathaway Stock’s 2026 Outlook And What It Means For Your PortfolioBy Catherine Brock

Key Takeaways Walmart U.S. sales rose 4.5%, while operating expenses increased 7%, driving expense deleverage. Higher depreciation and healthcare costs pushed Walmart U.S.'s operating expense rate up 56 basis points. Labor productivity partly offset cost pressure, while Walmart U.S. operating income increased 3.5%. Walmart Inc. (WMT - Free Report) posted solid sales growth in the first quarter of fiscal 2027, but operating expenses rose faster in its U.S. business. The resulting expense deleverage reflected higher depreciation and healthcare costs, even as labor productivity provided a partial offset.

Walmart U.S. net sales increased 4.5% year over year to $117.2 billion. Operating expenses rose 7% to $27.6 billion, while the operating expense rate jumped 56 basis points to 23.5%. The expense pressure primarily reflected higher depreciation tied to capital expenditures and higher healthcare costs from increased associate enrollment and medical cost inflation.

Business reorganization expenses also created an 11-basis-point headwind to the operating expense rate. Higher labor productivity helped offset some pressure, but overall expenses still grew faster than sales during the quarter. The expense dynamic was also visible at the consolidated level, where adjusted operating expenses as a percentage of net sales increased 23 basis points to 21.1%.

Walmart U.S. operating income jumped 3.5% to $5.9 billion compared with the 4.5% increase in net sales. The reported operating income rate declined 5 basis points to 5%. On an adjusted basis, operating income rose 5.7% to $6 billion, and the adjusted operating income rate improved 6 basis points to 5.1%.

The first-quarter figures show that Walmart U.S. generated sales growth while absorbing higher depreciation and healthcare expenses. The 56-basis-point increase in the operating expense rate captures the core issue, with cost growth outpacing revenue growth despite productivity-related relief.

How Kroger and Costco Compare on Expense LeverageThe Kroger Co. (KR - Free Report) also faced expense pressure in the first quarter of 2026. KR’s operating, general and administrative rate, excluding fuel and adjustment items, increased 16 basis points year over year, mainly due to planned investments in associate wages, additional store hours, training and new uniforms, partly offset by lower multi-employer pension contributions and productivity initiatives. Kroger’s total sales increased to $46.1 billion from $45.1 billion.

Costco Wholesale Corporation (COST - Free Report) showed a comparatively better expense trend in third-quarter fiscal 2026. The company’s SG&A rate improved 20 basis points to 8.96% from 9.16%. Excluding gas inflation, COST’s SG&A rate improved 2 basis points, with productivity improvements partly offset by higher healthcare costs. Costco’s net sales increased 11.6% to $69.15 billion, while operating income rose to $2.82 billion from $2.53 billion.

WMT Stock Price Performance, Valuation & EstimatesShares of Walmart have risen 7.6% over the past year compared with the industry’s growth of 5.6%.

WMT Price Performance Versus Industry
Image Source: Zacks Investment Research

From a valuation standpoint, WMT trades at a forward price-to-earnings ratio of 36.27, higher than the industry’s average of 33.08.

WMT Valuation Compared to Industry
Image Source: Zacks Investment Research

Key Takeaways Pfizer raised the lower end of the 2026 revenue guidance as new and acquired products gained traction.Pfizer's COVID sales continue to fall, while patent expirations are expected to weigh on revenues.Pfizer is advancing oncology and obesity pipelines to drive growth, with newer products posting strong gains. Pfizer (PFE - Free Report) stock has risen 6.9% since it announced second-quarter 2026 results on Aug. 4. Pfizer delivered a solid second quarter, beating estimates for both earnings and revenues. While earnings growth was flat year over year, revenues rose 1% on an operational basis. Strength in non-COVID products continued to offset declining sales of its COVID products, Comirnaty (COVID-19 vaccine - in partnership with BioNTech [(BNTX - Free Report) ]) and Paxlovid (oral antiviral). Excluding sales from BioNTech-partnered Comirnaty and Paxlovid, revenues increased 5% operationally.

Pfizer also raised the lower end of its 2026 revenue guidance, backed by continued strong performance of its new and acquired products. The company now expects revenues between $60.5 billion and $62.5 billion, compared with the previous range of $59.5 billion to $62.5 billion. The adjusted earnings guidance was reaffirmed at $2.80-$3.00 per share. However, the guidance now absorbs a 10 cents per share charge related to its licensing deal with Chinese biotech Innovent Biologics that will be recorded in the third quarter of 2026.

However, a single quarter’s results are not so important for long-term investors. To make an informed decision on whether to buy, sell or hold the stock, it is important to evaluate the company’s fundamentals by examining its key strengths and weaknesses.

First, let’s understand the negatives.

Declining Sales of PFE’s COVID ProductsDuring the pandemic, Pfizer generated extraordinary COVID-related sales from Comirnaty and Paxlovid. Those revenues have fallen sharply as the pandemic faded.

Sales of Pfizer’s COVID products, Comirnaty and Paxlovid, came down to around $11 billion in 2024 and $6.7 billion in 2025 from $56.7 billion in 2022. Sales of Comirnaty are declining due to a narrow recommendation for COVID vaccines in the United States, while Paxlovid is experiencing reduced demand from lower infection rates.

In 2026, Pfizer expects COVID-related revenues of approximately $4 billion, down from its previous forecast of $5 billion and below $6.7 billion generated in 2025. The decline reflects the continued normalization of COVID-19 infection rates and lower demand for COVID products. Consistent with this trend, sales of both Comirnaty and Paxlovid declined significantly during the first half of 2026.

PFE’s LOE HeadwindsPfizer faces a significant patent cliff later this decade. Pfizer expects a significant negative impact on revenues from the loss of exclusivity (“LOE”) cliff in the 2026-2030 period as several of its key products, including Eliquis, Ibrance, Xeljanz and Xtandi, face patent expirations. The LOE cliff is expected to hurt sales by approximately $1.1 billion in 2026, which is slightly lower than the prior expectation of $1.5 billion.

PFE’s 2026 Financial Outlook DullPfizer’s revenue and earnings guidance for 2026 indicates mostly flat to slightly negative year-over-year growth.

Pfizer expects total revenues for 2026 to be between $60.5 billion and $62.5 billion. The range represents a slight decline from 2025 revenues of $62.6 billion due to lower revenues from COVID products, Comirnaty and Paxlovid, and loss of revenues from the upcoming patent cliff.

In 2026, Pfizer expects adjusted earnings per share in the range of $2.80-$3.00, which represents a decline from the 2025 EPS of $3.22 due to the dilutive impact of 3SBio and Metsera deals, lower COVID revenues and higher taxes.

However, not everything is going wrong at Pfizer. Let’s see the positives.

PFE’s Non-COVID Portfolio Driving Its Next Phase of GrowthPfizer's business mix has changed significantly over the past few years. During the pandemic, the company became heavily dependent on COVID-19 products.  However, the company is gradually diversifying its portfolio through a combination of internal product launches like Abrysvo, Zavzpret, Elrexfio, Hympavzi, Litfulo and others, strategic acquisitions like Seagen, Metsera and Biohaven and the continued growth of several established brands like Vyndaqel, Padcev and Eliquis.

Pfizer expects its recently launched and acquired products to record continued double-digit growth. Reflecting this trend, sales from these products increased 22% operationally in the first quarter of 2026 and 18% in the second quarter.

PFE Enjoys a Strong Position in OncologyPfizer is one of the world’s leading oncology drugmakers with a broad portfolio of marketed cancer therapies as well as a deep oncology pipeline spanning multiple treatment modalities, including small molecules, antibody-drug conjugates (ADCs) and immuno-oncology biologics.

Oncology sales comprise around 27% of its total revenues. Its oncology revenues grew 5% in the first half of 2026, driven by drugs like Xtandi, Lorbrena, the Braftovi-Mektovi combination and Padcev. Pfizer considers Padcev to be a potential growth driver in the oncology segment and plans to invest in this asset.

Pfizer has ventured into the oncology biosimilars space and markets six biosimilars for cancer. It is also advancing its oncology clinical pipeline across areas such as breast, thoracic, gastrointestinal and blood cancers. Several oncology candidates have entered late-stage development, such as atirmociclib and sigvotatug vedotin. A regulatory application seeking approval of sasanlimab is also under review in the EU.

A key candidate in its oncology pipeline is PF-08634404, a dual PD-1/VEGF inhibitor in-licensed from Chinese biotech 3SBio in 2025. Pfizer has initiated nine studies, including two pivotal phase III studies for PF-08634404 in first-line metastatic colorectal cancer and first-line NSCLC. Pfizer aims to establish PF-08634404 as a potential backbone therapy across multiple tumor types. By 2030, Pfizer expects to have eight or more blockbuster oncology medicines in its portfolio.

Pfizer’s Fast Progressing Obesity PipelineThe company is rebuilding its pipeline in oncology and obesity, which it believes can drive growth in 2028 and beyond. Pfizer plans an extensive phase III program for berobenatide, its monthly GLP-1 receptor agonist added from last year’s Metsera acquisition, in 2026. Pfizer plans to start more than 20 obesity studies in 2026, including 10 phase III studies for berobenatide for obesity and obesity-related comorbidities, including knee osteoarthritis and obstructive sleep apnea. Three phase III studies on berobenatide have already begun. Pfizer is targeting the first of a series of potential approvals for berobenatide in 2028. Pfizer is also evaluating berobenatide in combination with an amylin-based therapy, PF'3945, in phase II studies. However, in the obesity space, Pfizer lags far behind leaders like Eli Lilly (LLY - Free Report) and Novo Nordisk (NVO - Free Report) .

PFE Stock’s Price, Estimates & ValuationPfizer’s stock has risen 7.5% so far this year compared with an increase of 11.4% for the industry.

PFE Stock Underperforms IndustryImage Source: Zacks Investment Research

From a valuation standpoint, Pfizer appears attractive relative to the industry and is trading below its five-year mean. Going by the price/earnings ratio, Pfizer’s shares currently trade at 9.08 forward earnings, significantly lower than 18.53 for the industry and slightly lower than the stock’s five-year mean of 9.28. The stock is also trading below most large drugmakers like Lilly, Novo Nordisk, AstraZeneca, AbbVie, J&J and others.

PFE Stock ValuationImage Source: Zacks Investment Research

The Zacks Consensus Estimate for 2026 earnings is stable at $2.97 per share, while that for 2027 has risen from $2.86 per share to $2.93 per share over the past 30 days.

PFE Estimate Movement                     Image Source: Zacks Investment Research

Stay Invested in PFE StockPfizer is navigating a difficult transition following the sharp decline in COVID-related sales from Comirnaty and Paxlovid. The market is concerned about Pfizer’s ability to replace declining COVID-related revenues and offset upcoming patent expirations through new product launches, pipeline development and contributions from acquisitions.

Although Pfizer’s 2026 sales guidance indicates minimal growth, the company expects a high single-digit revenue CAGR for five years, starting from year-end 2028. Pfizer expects its recently launched and acquired products, along with a strong pipeline, to help it return to growth from 2029 onward.

Pfizer's valuation is relatively inexpensive compared with many large pharmaceutical peers, and the stock offers one of the highest dividend yields in the sector. Pfizer’s dividend yield stands at around 6.4%

Pfizer’s significant cost reduction and efforts to improve R&D productivity measures are also driving profit growth. Pfizer expects approximately $9.7 billion in total net savings from its productivity enhancement initiative through 2029.

Long-term investors may consider retaining this Zacks Rank #3 (Hold) stock and can wait and see if Pfizer can successfully execute on its strategy and generate meaningful growth from its newer assets and restore revenue growth. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

War. Huh? What is it good for? Well, apparently it's good for oil prices and oil stocks -- Chevron (CVX +3.33%) in particular.

Global demand for oil amid Mideast turmoil spurred Chevron to raise its production forecast to between 4 million and 4.1 million barrels per day for this year, as TheFly.com reported late Friday. At the same time, Chevron advised that its capital spending will be closer to $18 billion than $19 billion.

Investors liked the news, and Chevron stock is up 3.2% through 10:15 a.m. ET this morning.

Image source: Getty Images.

More oil, less spending, more profit! More oil production at higher prices, and less capital spending? That's a recipe for higher profits and a near-term gusher of cash. Accordingly, Chevron told investors it anticipates growing its free cash flow by about $12.5 billion this year.

Added to the $16.6 billion the company generated last year, this implies 2026 FCF could surpass $29 billion, growing 75% year over year!

Today's Change

(

3.33

%) $

6.22

Current Price

$

192.78

How to value Chevron stock With $16.5 billion in FCF already produced this year, a $29.1 billion by year-end looks entirely achievable. Indeed, at its current pace, Chevron could potentially bury its own forecast and generate as much as $33 billion this year.

But let's work off the company's own, more conservative forecast.

Chevron has a $366 billion market capitalization. Dividing $29.1 billion into that gives us a 12.6x price-to-free cash flow ratio for Chevron stock. Factoring in a 3.8% dividend yield, I'd say any long-term growth rate of 9% or better would be good enough to make this stock a buy -- and analysts are forecasting more than a 16% long-term growth rate.

That's good enough for me. Chevron stock looks cheap enough to buy.

Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Chevron. The Motley Fool has a disclosure policy.

Key Takeaways Chord's Q2 2026 revenues rose 57.2% as oil output and oil and NGL realizations strengthened.Chord's oil production increased 5.6% to 165.4 MBbl/d, lifting oil's share of output.Chord's adjusted free cash flow surged to $413.4 million, supporting $147.4 million in share repurchases. Chord Energy Corporation (CHRD - Free Report) reported second-quarter 2026 adjusted earnings of $6.44 per share, up 259.8% from $1.79 a year ago. The bottom line missed the Zacks Consensus Estimate of $6.68 by 3.6%.

Total quarterly revenues rose 57.2% to $1.5 billion from $950.3 million. The top line beat the Zacks Consensus Estimate of $1.4 billion by 4.2%.

The strong quarterly revenues were driven by higher oil output, and stronger oil and natural gas liquids (NGL) realizations.

Total production reached 286.4 thousand barrels of oil equivalent per day (MBoe/d).

CHRD's Oil Output Moves HigherCHRD's oil production was 165.4 thousand barrels per day (MBbl/d), up 5.6% from 156.7 MBbl/d in the year-ago quarter. Oil represented 57.8% of total production, compared with 55.6% a year earlier.

Natural gas liquids production fell 2.0% to 53 thousand barrels per day (MBbl/d) from 54.1 MBbl/d recorded in the prior-year quarter. Natural gas production declined 4.2% to 408 million cubic feet per day (MMcf/d) from 425.9 MMcf/d in the second quarter of 2025. The company had 66 gross and 47 net operated wells turned in line during the quarter.

Chord Benefits From Stronger RealizationsChord's average oil sales price, excluding realized derivatives, increased 52.5% to $93.99 per barrel from $61.62 per barrel a year earlier. The average NGL sales price, excluding realized derivatives, increased 59.5% to $9.25 per barrel from $5.80 per barrel in the year-ago quarter.

Crude oil revenues rose to $1.42 billion, while NGL revenues increased to $44.6 million and natural gas revenues fell to $34.7 million.

CHRD's Cost Picture Shows Mixed TrendsLease operating expense (LOE) increased to $267.8 million from $257.0 million a year ago, while LOE per barrel of oil equivalent rose to $10.28 from $10.02. Production taxes rose to $125.9 million from $69.0 million.

Gathering, processing and transportation expense declined to $62.8 million from $74.1 million. Depreciation, depletion and amortization increased to $409.2 million from $377.0 million. Total select operating expenses were $865.7 million, up from $777.1 million.

CHRD's Cash Flow Supports Higher Capital ReturnsNet cash provided by operating activities reached $1.12 billion, up from $419.8 million a year ago. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) rose to $923.5 million from $547.2 million, while adjusted free cash flow increased to $413.4 million from $140.8 million.

CHRD returned 54% of adjusted free cash flow to shareholders in the quarter. It repurchased 1,104,346 shares for $147.4 million and declared a base dividend of $1.30 per share.

Chord’s Balance SheetAs of June 30, 2026, Chord had cash and cash equivalents of $611.6 million, while total debt was $1.50 billion and liquidity was $2.58 billion.

CHRD Keeps 2026 Capital Plan SteadyChord maintained its full-year 2026 oil-volume midpoint at 161 MBbl/d, with guidance to be in the range of 160.2-161.8 MBbl/d. Total production is projected to be in the range of 278.2-281.8 MBoe/d, while capital expenditures are expected to be between $1.36 billion and $1.44 billion.

For the third quarter, oil volumes are expected to be in the range of 161.5-164.5 Mbo/d and capital spending between $360 million and $390 million. Chord raised the full-year LOE midpoint to $10.30 per barrel of oil equivalent (Boe), reflecting additional production-enhancement initiatives, higher workover costs and higher non-operated LOE. The company expects about $3.0 billion of adjusted EBITDA and $1.3 billion of adjusted free cash flow for 2026, assuming $75 WTI and $3 Henry Hub in the second half.

CHRD’s Zacks Rank & Key PicksChord currently carries a Zacks Rank #4 (Sell).

Some better-ranked stocks from the energy sector are PBF Energy Inc. (PBF - Free Report) , Valero Energy Corporation (VLO - Free Report) and Cactus, Inc. (WHD - Free Report) . PBF sports a Zacks Rank #1 (Strong Buy), while VLO and WHD carry a Zacks Rank #2 (Buy) each, at present. You can see the complete list of today’s Zacks Rank #1 stocks here.

PBF reported second-quarter 2026 adjusted earnings of $6.22 per share, surpassing the Zacks Consensus Estimate of $4.05 per share.

As of June 30, 2026, PBF had total debt of $1.75 billion, and cash and cash equivalents of $894.1 million.

Valero reported second-quarter 2026 adjusted earnings of $12.54 per share, which beat the Zacks Consensus Estimate of $9.87 per share.

As of June 30, 2026, VLO had total debt of $9.10 billion, and cash and cash equivalents of $7.87 billion.

Cactus reported second-quarter 2026 adjusted earnings of 93 cents per share, surpassing the Zacks Consensus Estimate of 71 cents per share.

As of June 30, 2026, WHD had cash and cash equivalents of $365 million.

Barrick Gold Corp. (TSX:ABX, NYSE:GOLD) shares fell 8% on Monday after the company reported second quarter results that showed strong year-over-year growth but came in below Wall Street estimates.

The company reported adjusted earnings of $0.82 per share for the quarter, below the $0.84 consensus estimate.

Revenue rose 44% year over year to $5.29 billion, although that was below forecasts of about $5.67 billion.

Barrick’s second-quarter gold production increased 11% from the first quarter to 796,000 ounces, exceeding its guidance range of 730,000 to 770,000 ounces. The company attributed the increase to an ahead-of-schedule ramp-up at Loulo-Gounkoto, a faster-than-expected recovery at Pueblo Viejo following planned maintenance and record underground tonnes at Cortez as Goldrush continued to ramp up.

Gold cost of sales was $1,993 per ounce, compared with $1,654 a year earlier, while all-in sustaining costs rose 11% year over year to $1,866 per ounce. Barrick attributed the higher costs in part to lower grades processed at several operations, higher fuel prices and increased royalties associated with higher realized gold prices.

Copper production fell 5% year over year to 56,000 tonnes. Copper cost of sales, C1 cash costs and all-in sustaining costs all increased from the prior-year period, with Barrick citing higher royalties and fuel prices.

For 2026, Barrick said it remains on track to meet its existing production and cost guidance. The company continues to expect gold production of 2.90 million to 3.25 million ounces for the year.

Gold cost of sales is forecast at $1,870 to $2,070 per ounce, while total cash costs are expected to range from $1,330 to $1,470 per ounce. All-in sustaining costs are projected at $1,760 to $1,950 per ounce. The guidance is based on an assumed gold price of $4,500 per ounce.

Barrick maintained its copper production guidance of 190,000 to 220,000 tonnes for the year. Copper cost of sales is expected at $3.05 to $3.35 per pound, with C1 cash costs of $2.20 to $2.45 per pound and all-in sustaining costs of $3.45 to $3.75 per pound. The copper guidance assumes a price of $5.50 per pound.

Barrick also reduced its 2026 total attributable capital expenditure guidance to $3.8 billion to $4.2 billion, from its previous range of $4 billion to $4.45 billion. The company said the reduction primarily reflects lower expected spending at the Reko Diq project.

“We delivered our third quarter in a row with excellent operational and financial performance,” Barrick CEO Mark Hill said in a statement. “We beat the top end of our gold production guidance and generated much higher earnings and cash flow than a year ago. We also advanced our growth pipeline, with good progress at Lumwana and Fourmile.”

Newmont deal The company also announced an agreement with Newmont that expands the Nevada Gold Mines joint venture and resolves outstanding disputes between the two companies. Under the agreement, Barrick will contribute Fourmile while Newmont will contribute the Mike and Fiberline properties, creating a Nevada complex with nearly 100 million ounces of gold, according to Barrick. Newmont will also make a $1.95 billion cash payment to Barrick.

The agreement includes Newmont's consent to Barrick's planned initial public offering of its North American gold assets. Barrick said the IPO remains on track for completion by the end of the year, with Hill set to lead the new company as CEO following the separation.

“We achieved an historic agreement with Newmont. Newmont has consented to the IPO and the parties have agreed to expand NGM with the early vend-in of our excluded properties, as well as settling all disputes,” Hill said.

“Through this agreement with our joint venture partner, we have substantially extended the asset base, and provided greater flexibility and value.”

Key Takeaways Take-Two kept FY27 Net Bookings at $8B-$8.2B, about 20% growth at the midpoint.GTA VI preorders are unprecedented, but Take-Two declined unit forecasts and held guidance.NBA 2K26 sold over 12M units as recurrent spending rose 7% and daily active users climbed 15%. Take-Two Interactive Software, Inc. (TTWO - Free Report) entered fiscal 2027 with first-quarter Net Bookings slightly above guidance, while management kept its full-year outlook unchanged ahead of the Nov. 19 launch of Grand Theft Auto VI.

Chief executive officer Strauss Zelnick framed the year as an inflection point, but the call also showed restraint around translating record GTA VI preorders into higher guidance before launch.

Goldstein reiterated fiscal 2027 Net Bookings guidance of $8 billion to $8.2 billion, representing about 20% growth at the midpoint. The company still expects recurrent consumer spending to be in line with fiscal 2026 and accounts for 64% of Net Bookings.

Take-Two reported fiscal first-quarter earnings of 36 cents per share, which beat the Zacks Consensus Estimate of 31 cents. Revenues of $1.39 billion beat the estimate of $1.35 billion.

Take-Two Keeps GTA VI Launch at CenterCEO Strauss Zelnick said confidence in the Nov. 19 release of Grand Theft Auto VI remains high, supported by what management described as an exceptional start to preorders.

Zelnick said the preorder level is unprecedented for Take-Two and the industry, but he declined to translate that demand into unit expectations. He stressed that preorders can be canceled and that no units have yet been sold.

President Karl Slatoff also pointed to continued GTA Online engagement, saying recent content has reactivated players while the company maintains a stable update cadence and significant support for the service.

TTWO Leans on NBA 2K and Recurrent SpendingCEO Strauss Zelnick said NBA 2K26 sold more than 12 million units, up 9% from NBA 2K25. Recurrent consumer spending for the franchise grew 7%, while average daily active users increased 15%.

CFO Lainie Goldstein said companywide recurrent consumer spending declined 1%, better than guidance for a 3% decline, and represented 84% of first-quarter Net Bookings.

For the fiscal second quarter, Goldstein guided Net Bookings to $1.62 billion to $1.67 billion and expects recurrent consumer spending to decline about 5%, with mobile down and NBA 2K and Grand Theft Auto growing.

Take-Two Addresses Mobile and PricingA TD Cowen analyst asked about signs of weaker mobile demand. CEO Strauss Zelnick said Take-Two is not seeing consumer pullback, though user acquisition costs face some pressure and Color Block Jam has a tougher year-over-year comparison.

A BMO Capital Markets analyst questioned the decision to price GTA VI at $80 while keeping NBA 2K27 at $70. Zelnick said the company’s objective is to deliver more consumer value rather than maximize price.

Zelnick also said direct-to-consumer distribution remains a growth area in mobile and has had a material positive effect on margins.

TTWO Q&A Tempers Preorder ExpectationsA Wells Fargo analyst asked whether strong GTA VI preorders could pull demand forward. CEO Strauss Zelnick acknowledged that outcome while reiterating that management is not raising guidance before the title launches.

A Citi analyst also pressed for a framework linking preorders to eventual sales. Zelnick again declined to provide unit expectations, emphasizing that the unprecedented preorder levels make historical comparisons less useful.

The repeated caution contrasted with management’s strong confidence in the title and reinforced the decision to keep the fiscal 2027 Net Bookings range unchanged.

Take-Two Focuses on Sustaining New ScaleCEO Strauss Zelnick said major releases have historically influenced Take-Two beyond a single quarter, while the company’s pipeline, live services and catalog provide additional growth avenues.

Management also highlighted international expansion, selective accretive M&A and live-service enhancements as priorities for sustaining a higher scale after fiscal 2027.

TTWO Zacks Signals Favorable Rank, Mixed StylesTTWO carries a Zacks Rank #2 (Buy). Its Value Score is F, while Growth and Momentum Scores are C and the VGM Score is D. Under the Zacks framework, the #2 rank is favorable, while A and B are the stronger Style Score grades. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The combination therefore provides a positive earnings-estimate-revision signal but weaker support from the Style Scores. The Zacks Rank can change as analysts revise estimates following the just-reported results.

Key Takeaways Costco reported July comparable sales growth of 8.9% across regions.COST's digital comparable sales rose 17.7%, extending strong online momentum.Costco's net sales climbed to $23.12 billion, supported by warehouse and digital growth. Costco Wholesale Corporation’s (COST - Free Report) July sales results reflected resilient consumer demand, with comparable sales advancing across regions and digitally enabled sales maintaining strong momentum. The company continues to benefit from its value-driven pricing, quality merchandise and broad warehouse footprint, which are helping attract shoppers in a cautious consumer environment.

Breaking Down Costco’s July Sales NumbersFor the four weeks ended Aug. 2, 2026, Costco reported an 8.9% year-over-year increase in total comparable sales. Regionally, comparable sales rose 10.3% in the United States, 4.2% in Canada and 6% in Other International markets. This compares with total comparable sales growth of 8.8% in June and 12.5% in May.

Excluding the impacts of gasoline prices and foreign exchange, comparable sales increased 6.9% in the United States, 4.9% in Canada and 6.6% in Other International markets. Overall, total comparable sales, excluding these factors, rose 6.6% in July compared with increases of 7% in June and 8% in May.

Digitally enabled comparable sales remained a key growth driver, rising 17.7% in July, or 18.2% after adjusting for gasoline and foreign exchange impacts. Although growth moderated from 20.9% in June and 21.1% in May, the double-digit increase underscores sustained momentum in Costco’s digital channel.

Costco’s July net sales increased 10.7% year over year to $23.12 billion from $20.89 billion. This compares with net sales growth of 10.6% in June and 14.5% in May.

Costco appears to have several factors supporting continued sales growth, including its value proposition, steady warehouse traffic and rapidly expanding digital business. July's broad-based comparable sales gains also suggest that growth is not dependent on a single market.

How Costco Compares With Walmart and BJ’s WholesaleWalmart Inc. (WMT - Free Report) also displayed steady sales momentum in the first quarter of fiscal 2027. Walmart U.S. comparable sales, excluding fuel, increased 4.1%, supported by a 3% rise in transactions and strong e-commerce activity. E-commerce contributed roughly 530 basis points to comps, while U.S. e-commerce sales advanced 26%. Walmart noted broad-based share gains as increased customer transactions and digital growth supported sales performance.

BJ's Wholesale Club Holdings, Inc. (BJ - Free Report) posted a 6.3% increase in total comparable club sales in the first quarter of fiscal 2026, while comps, excluding gasoline, rose 1.5%. Digital remained a notable sales driver for BJ’s Wholesale, with digitally enabled comparable sales jumping 28% and two-year stacked growth reaching 63%. BJ’s Wholesale also recorded positive traffic and continued share gains, while grocery, perishables and sundries supported its core consumables business.

What the Latest Metrics Say About CostcoCostco has seen its shares tumble 5.2% over the past three months against the industry’s rise of 4.5%. 
 

Image Source: Zacks Investment Research

From a valuation standpoint, Costco's forward 12-month price-to-earnings ratio stands at 42.33, higher than the industry’s ratio of 31.58. However, it is trading below its 12-month median level of 45.87, indicating some moderation in valuation despite sustained investor confidence in the stock.
 

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Costco’s current financial-year sales and earnings per share implies year-over-year growth of 9.7% and 13.5%, respectively. For the next fiscal year, the consensus estimate indicates a 7.8% rise in sales and 10.2% growth in earnings.
 

Image Source: Zacks Investment Research

Costco currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Did you analyze how Airbnb, Inc. (ABNB - Free Report) fared in its international operations for the quarter ending June 2026? Given the widespread global presence of this company, scrutinizing the trends in international revenues becomes imperative to assess its financial strength and future growth possibilities.

In the current global economy, which is more interconnected than ever, a company's success in penetrating international markets is crucial for its financial health and growth journey. Investors must understand a company's dependence on overseas markets, as this offers a window into the company's earnings stability, its ability to benefit from varied economic cycles and its potential for long-term growth.

Being present in foreign markets serves as protection against local economic declines and helps benefit from more rapidly expanding economies. Yet, such expansion also introduces challenges related to currency fluctuations, geopolitical uncertainties and varied market behaviors.

Upon examining ABNB's recent quarterly performance, we noticed several interesting patterns in the revenue generated from its international segments, which are commonly analyzed and observed by Wall Street experts.

The company's total revenue for the quarter amounted to $3.61 billion, marking an increase of 16.5% from the year-ago quarter. We will next turn our attention to dissecting ABNB's international revenue to get a clearer picture of how significant its operations are outside its main base.

A Look into ABNB's International Revenue StreamsLatin America generated $291 million in revenues for the company in the last quarter, constituting 8.1% of the total. This represented a surprise of -34.9% compared to the $447 million projected by Wall Street analysts. Comparatively, in the previous quarter, Latin America accounted for $451 million (16.8%), and in the year-ago quarter, it contributed $231 million (7.5%) to the total revenue.

Asia Pacific accounted for 8.3% of the company's total revenue during the quarter, translating to $298 million. Revenues from this region represented a surprise of -0.67%, with Wall Street analysts collectively expecting $300 million. When compared to the preceding quarter and the same quarter in the previous year, Asia Pacific contributed $342 million (12.8%) and $255 million (8.2%) to the total revenue, respectively.

During the quarter, Europe, the Middle East, and Africa contributed $1.43 billion in revenue, making up 39.5% of the total revenue. When compared to the consensus estimate of $1.41 billion, this meant a surprise of +1.35%. Looking back, Europe, the Middle East, and Africa contributed $747 million, or 27.9%, in the previous quarter, and $1.23 billion, or 39.8%, in the same quarter of the previous year.

International Market Revenue ProjectionsThe current fiscal quarter's total revenue for Airbnb, as projected by Wall Street analysts, is expected to reach $4.54 billion, reflecting an increase of 10.9% from the same quarter last year. The breakdown of this revenue by foreign region is as follows: Latin America is anticipated to contribute 7.6% or $343 million, Asia Pacific 7% or $320 million and Europe, the Middle East, and Africa 50.4% or $2.29 billion.

Analysts expect the company to report a total annual revenue of $14.06 billion for the full year, marking an increase of 14.8% compared to last year. The expected revenue contributions from Latin America, Asia Pacific and Europe, the Middle East, and Africa are projected to be 13.1% ($1.84 billion), 9.7% ($1.36 billion) and 38.8% ($5.45 billion) of the total revenue, in that order.

Wrapping UpAirbnb's leaning on foreign markets for its revenue stream presents a mix of chances and challenges. Therefore, a vigilant watch on its international revenue movements can greatly aid in projecting the company's future direction.

In an era of growing international ties and escalating geopolitical disputes, financial analysts on Wall Street pay keen attention to these developments to fine-tune their earnings estimations for businesses operating across borders. It's important to note, however, that a range of additional variables, like a company's local market status, also play a crucial role in shaping these forecasts.

Emphasizing a company's shifting earnings prospects is a key aspect of our approach at Zacks, especially since research has proven its substantial influence on a stock's price in the short run. This correlation is positively aligned, meaning that improved earnings projections tend to boost the stock's price.

Boasting a remarkable track record that's been externally verified, the Zacks Rank, our unique stock rating system, leverages changes in earnings projections to function as a reliable gauge for predicting short-term stock price movements.

Currently, Airbnb holds a Zacks Rank #3 (Hold), signifying its potential to match the overall market's performance in the forthcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Airbnb, Inc.'s Recent Stock Market PerformanceThe stock has increased by 19.8% over the past month compared to the 3.4% increase of the Zacks S&P 500 composite. Meanwhile, the Zacks Consumer Discretionary sector, which includes Airbnb,has increased 1.1% during this time frame. Over the past three months, the company's shares have experienced a gain of 34% relative to the S&P 500's 6% increase. Throughout this period, the sector overall has witnessed a 0.5% decrease.

Key Takeaways AMC's European attendance jumped 17.9%, while adjusted EBITDA surged 337% to $35.8 million.Recliner seating, ODEON Luxe conversions and premium screens offer further European growth opportunities.A strong 2026 movie slate and disciplined investment could help sustain AMC's international momentum. AMC Entertainment Holdings (AMC - Free Report) delivered a standout second-quarter 2026 performance, with its European operations emerging as a key growth driver.

Attendance across Europe jumped 17.9% year over year, outpacing the relevant industry’s 16.2% growth. More strikingly, European adjusted EBITDA surged 337% to $35.8 million, helping demonstrate the strong operating leverage in AMC’s international business.

The company appears well positioned to sustain this momentum. Management highlighted significant opportunities to upgrade European theaters, particularly through recliner seating and ODEON Luxe conversions. These initiatives have generated high returns, while AMC can also secure co-funding from landlords and technology partners, reducing the capital burden. Management noted that recliner penetration in Europe remains higher than in the United States, indicating further room for premiumization.

Premium large-format screens offer another avenue for growth. AMC plans to expand its premium and extra-large-format footprint across the United States and Europe, benefiting from higher ticket prices and strong demand for enhanced moviegoing experiences.

A strong movie slate should also support attendance. Management expects 2026 to be the strongest post-pandemic year for the global box office, providing a favorable backdrop for AMC’s European theaters.

However, currency movements can affect reported international results, with European currency appreciation contributing about 2% to second-quarter international revenue and EBITDA growth. Overall, continued attendance gains, premium upgrades and disciplined investment suggest Europe could remain an important growth engine for AMC.

AMC’s Price Performance, Valuation & EstimatesShares of AMC have surged 104% in the past six months compared with the industry’s 5.1% growth. In the same time frame, AMC has outperformed industry players like Cinemark Holdings, Inc. (CNK - Free Report) and The Marcus Corporation (MCS - Free Report) .

AMC’s Price Performance
Image Source: Zacks Investment Research

From a valuation standpoint, AMC trades at a forward price-to-sales (P/S) multiple of 0.41, below the industry’s average of 2.97. Cinemark and Marcus have P/S ratios of 0.97 and 0.82, respectively.

AMC’s P/S Ratio (Forward 12-Month) vs. Industry
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for AMC’s 2026 loss per share indicates a 77.1% year-over-year improvement. Conversely, industry players like Cinemark and Marcus are likely to witness growth of 125% and 652.9%, respectively, year over year in 2026 earnings.

Image Source: Zacks Investment Research

AMC’s Zacks RankAMC currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

I keep hitting the buy button on Broadcom (NASDAQ:AVGO | AVGO Price Prediction) for a simple reason: it is the rare AI story where the growth is already booked, the cash is already showing up, and I do not have to guess which hyperscaler wins the compute race. That last part is the whole thesis. My money keeps landing here because Broadcom holds a near-monopoly on high-speed AI Ethernet switching while acting as the primary beneficiary of hyperscalers moving away from general-purpose GPUs toward custom silicon. When Google, Meta, OpenAI, and Anthropic each commit to their own accelerators, Broadcom’s XPUs and switches sit on the bill of materials either way.

The Receipts Behind the Conviction Q2 FY2026 revenue landed at $22.187 billion, up 47.9% year over year, with AI semiconductor revenue of $10.80 billion growing 143%. Non-GAAP EPS of $2.44 extended the beat streak to 8 consecutive quarters. Free cash flow of $10.262 billion converted at 46% of revenue, and adjusted EBITDA margin hit 69%. Cash on the balance sheet more than doubled year over year to $19.628 billion.

Then there is the forward book. Q3 guidance calls for ~$29.40 billion in revenue, with AI semiconductor revenue guided to $16.00 billion, a 200%+ YoY jump. Q2 AI bookings came in at over $30 billion against $10.8 billion shipped. Hock Tan said “Our visibility now extends into 2028” and reiterated fiscal 2027 AI revenue in excess of $100 billion.

The income piece keeps me anchored. Broadcom has raised its dividend for 15 consecutive years since fiscal 2011, with the most recent 10% raise to $0.65 per quarter. The yield sits at 0.6%, so this is a dividend growth story, not an income story. Forward P/E of 23 against triple-digit AI growth is the valuation I keep coming back to.

Why Not NVIDIA or Marvell NVIDIA (NASDAQ:NVDA) is the reflexive AI pick. My money goes to Broadcom instead because the hyperscaler diversification trade is the whole point of my thesis. Networking alone made up almost 40% of Q2 AI revenue, and Tan called Broadcom “the de facto standard in the industry” in co-packaged optics. Marvell Technology (NASDAQ:MRVL) plays in the same custom silicon lane, but it does not sit on partnerships covering 10 gigawatts in 2027 across Google, Meta, OpenAI, and Anthropic. Advanced Micro Devices (NASDAQ:AMD) is a compelling GPU alt, but it competes with the very customers Broadcom serves.

The Real Risk Customer concentration is real. A handful of hyperscalers drive the AI number, and if any one of them pulls back, the growth curve bends. I also see the insider tape: 59 disposal transactions against 3 acquisitions in the last three months, with co-founder Henry Samueli leading the selling. What keeps me buying anyway is the booking backlog. Orders placed today for 2027 and 2028 delivery are harder to unwind than a quarterly sentiment shift, and the $56 billion full-year 2026 AI target is already largely contracted.

Why the Buy Button Stays Active Analysts carry 44 Buy ratings against 0 Sells with a target of $527.88 versus the $427.76 close. That is the market’s math. Mine is simpler: Broadcom gets paid whether the winning AI chip is designed in Santa Clara, Mountain View, or Menlo Park, and it hands me a rising dividend while I wait for 2028 to arrive.

Contact [email protected] for any questions or corrections.

SPRINGDALE, Ark., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (the “Company” or “we”) (NYSE: TSN) announced today that it is offering to purchase for cash each series (each, a “Series”) of the notes issued by the Company listed in the following table (the “Notes”) (i) in accordance with, and in the order of, the corresponding Acceptance Priority Levels (as defined below) and (ii) subject to the Maximum Tender Cap (as defined below), the 2027 Tender Sub-Cap (as defined below), the 5.400% 2029 Tender Sub-Cap (as defined below) and possible pro rata allocation, upon the terms and subject to the conditions set forth in the Offer to Purchase (as defined below), including the Financing Condition (as defined below). The offers to purchase with respect to each Series of Notes are referred to herein as the “Offers” and each, an “Offer.” Each Offer is made upon the terms and subject to the conditions set forth in the offer to purchase, dated August 10, 2026 (as may be amended or supplemented from time to time, the “Offer to Purchase”). Capitalized terms used but not defined in this press release have the meanings given to them in the Offer to Purchase.